Heart Failure Clinical Trial
— PD-HFOfficial title:
PD-HF: A Multi-centre Randomised Controlled Trial of Intermittent Peritoneal Dialysis With Icodextrin-based Solutions on Patients With Severe Heart Failure and Stage 3-4 Chronic Kidney Disease
Verified date | January 2020 |
Source | University of Nottingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This trial is to establish whether ultrafiltration by peritoneal dialysis is a clinically effective treatment for patients with severe heart failure and moderate chronic kidney disease, thus improving quality of life and symptoms.
Status | Terminated |
Enrollment | 11 |
Est. completion date | June 2017 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Severe heart failure (NYHA grade III or IV) - Chronic kidney disease stage 3-4 - Fluid overload resistant to diuretics OR hospital admission for HF in last 6 months - Left ventricular ejection fraction =40% in last 2 years (moderate/severe) - Using optimal HF medication for = 4 weeks including ACE-inhibitor (angiotensin-converting-enzyme inhibitor) OR angiotensin receptor blocker AND aldosterone antagonist AND beta-blocker unless intolerant and without dose change for = 4 weeks - Appropriately screened for revascularization and/or cardiac resynchronization therapy if clinically indicated. Exclusion Criteria: - Does not wish to participate - Mental incapacity to consent - CKD stage 5 - Normal renal excretory function - Haemodynamically significant valvular disease amenable to surgery - Cardiac or renal transplantation - Considered by the investigator to unsuitable for PD due to previous abdominal surgeries, peritonitis, social circumstances or other reason |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Derby Teaching Hospitals NHS Foundation Trust | Derby | Derbyshire |
Lead Sponsor | Collaborator |
---|---|
University of Nottingham | British Heart Foundation |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Episodes of PD associated peritoneal infection | Recording the numbers of PD associated peritoneal infections | Baseline to week 28 | |
Other | Adverse events spontaneously reported during the study | Recording and reporting adverse events | Baseline to week 28 | |
Other | Is the Derby Evaluation of Illness online visual analogue scale more sensitive than pen and ink questionnaires | Comparison between the scores from pen and ink questionnaires and the online visual analogue scale | Baseline to week 28 | |
Primary | The primary end-point is a change of 25 metres walked | 6 Minute Walk Test | Baseline to week 28 | |
Secondary | Change in KCCQ score | Kansas City Cardiomyopathy Questionnaire | Baseline to week 28 | |
Secondary | Change in SF36 score | Short Form 36 questionnaire | Baseline to week 28 | |
Secondary | Change in Derby Evaluation of Illness online visual analogue scale | Derby Evaluation of Illness online visual analogue scale | Baseline to week 28 | |
Secondary | Heart Failure related hospitalisations | Recording the number of hospitalisations relating to Heart Failure | Baseline to week 28 | |
Secondary | All cause hospitalisations | Recording the number of hospitalisations for all causes | Baseline to week 28 | |
Secondary | Heart failure related mortality | Recording the number of heart failure deaths | Baseline to week 28 | |
Secondary | All cause mortality | Recording the number of all cause deaths | Baseline to week 28 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|